Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. Issue 2 (December 2015)

• Record Type: Journal Article
• Authors: Kim, Soon Sun; Cho, Hyo Jung; Won, Je Hwan; Bae, Jae Ik; Kang, Dae Ryong; Lee, Jung-Dong; Shin, Sung Jae; Lee, Kee Myung; Yoo, Byung Moo; Kim, Jai Keun; Lee, Jei Hee; Ahn, Seon Joo; Park, Ju Han; Cho, Sung Won; Cheong, Jae Youn
• Is Part Of: Cytokine. Volume 76:Issue 2(2015)
• Page Start: 449
• Page End: 457
• Publication Date: 2015-12
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2015.07.001
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st005">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0005">The study measured pretreatment levels of 11 cytokines including IL-8.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0010">TACE refractoriness and LT-free survival were evaluated in 119 patients with HCC.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0015">Combined AFP and IL-8 levels independently predicted overall TACE refractoriness.</p> </list-item> <list-item id="o0020"> <label></label> <p id="p0020">High IL-8 level was also associated with poor LT-free survival.</p> </list-item> <list-item id="o0025"> <label></label> <p id="p0025">Serum IL-8 level is a useful prognostic marker in TACE-treated patients with HCC.</p> </list-item> </list> </p> </sec> </abstract>